AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis.
about
AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
AML associated oncofusion prot ...... vels and drive leukemogenesis.
@en
AML associated oncofusion prot ...... vels and drive leukemogenesis.
@nl
type
label
AML associated oncofusion prot ...... vels and drive leukemogenesis.
@en
AML associated oncofusion prot ...... vels and drive leukemogenesis.
@nl
prefLabel
AML associated oncofusion prot ...... vels and drive leukemogenesis.
@en
AML associated oncofusion prot ...... vels and drive leukemogenesis.
@nl
P2093
P2860
P356
P1433
P1476
AML associated oncofusion prot ...... vels and drive leukemogenesis.
@en
P2093
Abhishek A Singh
Amit Mandoli
Koen H M Prange
Marko Laakso
P2860
P304
12855-12865
P356
10.18632/ONCOTARGET.14150
P407
P577
2016-12-24T00:00:00Z